64241-34-5 Usage
Description
Cadralazine is a vasodilatory antihypertensive reportedly better-tolerated and
longer-acting than hydralazine. It is useful as a second-line treatment in the management
of hypertension.
Originator
ISF;（Smith Mine) (Italy)
Brand name
Cadraten 21 cpr 20 mg;Cadraten 30 cpr 10 mg;Cadraten 30 cpr 15 mg;Cadratin;Cadrilan.
World Health Organization (WHO)
Cadralazine, a peripheral vasodilator, was introduced in 1989 for
the treatment of arterial hypertension.In 1992, its association with serious side
effects led to the refusal of registration in Norway. Animal experiments have
demonstrated drug-related impairment of thyroid function as well as potential carcinogenicity and genotoxicity. It remains available for treatment of hypertension
in Italy.
Check Digit Verification of cas no
The CAS Registry Mumber 64241-34-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,2,4 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 64241-34:
(7*6)+(6*4)+(5*2)+(4*4)+(3*1)+(2*3)+(1*4)=105
105 % 10 = 5
So 64241-34-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19)
